Search Results - "THURMOND, L. M"

Refine Results
  1. 1

    A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients by Fava, M, Johe, K, Ereshefsky, L, Gertsik, L G, English, B A, Bilello, J A, Thurmond, L M, Johnstone, J, Dickerson, B C, Makris, N, Hoeppner, B B, Flynn, M, Mischoulon, D, Kinrys, G, Freeman, M P

    Published in Molecular psychiatry (01-10-2016)
    “…We wanted to examine tolerability and efficacy of NSI-189, a benzylpiperizine-aminiopyridine neurogenic compound for treating major depressive disorder (MDD)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Subcutaneous administration of CAMPATH-1H: clinical and biological outcomes by Schnitzer, T J, Yocum, D E, Michalska, M, Balius, R, Snider, M E, Hays, A, Thurmond, L M, Johnston, J M

    Published in Journal of rheumatology (01-06-1997)
    “…A 24 week study of subcutaneous (sq) dosing with titration of CAMPATH-1H (C1H) dose against the circulating CD4+ T cell count in patients with rheumatoid…”
    Get more information
    Journal Article
  4. 4

    A kinetic enzyme immunoassay for the quantitation of antibodies to a humanized monoclonal antibody in human serum by Thurmond, L.M., Reese, M.J., Donaldson, R.J., Orban, B.S.

    “…A kinetic enzyme immunoassay was developed and validated to quantitate human antibodies to the humanized monoclonal antibody CAMPATH 1 C1H is a trademark of…”
    Get full text
    Journal Article
  5. 5

    Improved biodistribution, tumor targeting, and reduced immunogenicity in mice with a gamma 4 variant of Campath-1H by J T Hutchins, F C Kull, Jr, J Bynum, V C Knick, L M Thurmond, P Ray

    “…Radiolabeled antibodies have shown promise for the treatment of lymphoma and for solid tumor targeting. Campath-1H is a humanized monoclonal antibody that…”
    Get full text
    Journal Article
  6. 6

    Differential neutralizing activity of human antibodies in interferon antiviral and natural killer cell bioassays by Thurmond, L M, Reese, M J

    Published in Journal of interferon & cytokine research (01-10-1997)
    “…The ability of interferon-alpha (IFN-alpha) to augment the cytotoxicity of human natural killer (NK) cells was used to probe the neutralization capacity of…”
    Get more information
    Journal Article
  7. 7

    Immunosuppression following exposure to 7,12-dimethylbenz[a]anthracene (DMBA) in Ah-responsive and Ah-nonresponsive mice by Thurmond, L M, Lauer, L D, House, R V, Cook, J C, Dean, J H

    Published in Toxicology and applied pharmacology (01-12-1987)
    “…Recent reports suggest that the immunotoxicity of certain polycyclic aromatic hydrocarbons is associated with the Ah locus in mice. To test whether…”
    Get more information
    Journal Article
  8. 8

    Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro by Thurmond, L M, House, R V, Lauer, L D, Dean, J H

    Published in Toxicology and applied pharmacology (01-05-1988)
    “…The effects of the immunosuppressive polycyclic aromatic hydrocarbon (PAH) 7,12-dimethylbenz[a]anthracene (DMBA) were studied directly by in vitro exposure of…”
    Get more information
    Journal Article
  9. 9

    Blastomyces dermatitidis chemotactic factor: kinetics of production and biological characterization evaluated by a modified neutrophil chemotaxis assay by THURMOND, L. M, MITCHELL, T. G

    Published in Infection and Immunity (01-10-1984)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  10. 10

    Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects by King, Deborah, Tomkins, Sarah, Waters, Anele, Easterbrook, Philippa J., Thurmond, Linda M., Thorborn, Daren E., Raffi, Francois, Kemeny, D. Mike, Vyakarnam, Annapurna

    Published in Journal of Allergy and Clinical Immunology (01-05-2005)
    “…The clinical treatment of patients with HIV and adverse drug events may be enhanced by an understanding of the underlying mechanisms. About 4% of patients with…”
    Get full text
    Journal Article
  11. 11

    Functional and biochemical disposition of 7,12-dimethylbenz[a]anthracene in murine lymphoid cells by Thurmond, L M, Tucker, A N, Rickert, D E, Lauer, L D, Dean, J H

    Published in Chemico-biological interactions (1989)
    “…The metabolism of the polycyclic aromatic hydrocarbon (PAH) 7,12-dimethylbenz[a]anthracene (DMBA) was studied in murine lymphocytes. This carcinogen has…”
    Get more information
    Journal Article
  12. 12

    Effect of short-term inhalation exposure to 1,3-butadiene on murine immune functions by Thurmond, L M, Lauer, L D, House, R V, Stillman, W S, Irons, R D, Steinhagen, W H, Dean, J H

    Published in Toxicology and applied pharmacology (01-11-1986)
    “…Interest in 1,3-butadiene (BD) as a potential immunomodulator was prompted by reports of an increased incidence of neoplasia in humans exposed to BD during the…”
    Get more information
    Journal Article
  13. 13

    Inhibitory Activity of Synthetic Peptide Antibiotics on Feline Immunodeficiency Virus Infectivity In Vitro by Ma, Jia, Kennedy-Stoskopf, Suzanne, Jaynes, Jesse M, Thurmond, Linda M, Tompkins, Wayne A

    Published in Journal of Virology (01-10-2002)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14

    Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism by THURMOND, Linda M, STIMMEL, Julie B, INGRAM, Adrienne C, RYAN, Christian H, MURRAY, Doris M, EBERWEIN, Derek J, WITHERSPOON, Sam M, KNICK, Vincent C

    Published in Cancer Immunology, Immunotherapy (01-07-2003)
    “…Ep-CAM antigen expression was shown to vary by phase across the cell cycle. Following pretreatment of various adenocarcinoma cells in culture with clinically…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Immunochemical characterization of human antibodies to lymphobiastoid interferon by THURMOND, L. M., REESE, M. J.

    Published in Clinical and experimental immunology (01-12-1991)
    “…SUMMARY Antibodies produced in recurrent respiratory papillomatosis (RRP) patients treated with Iymphoblastoid interferon (1yIKN) may neutralize antiviral…”
    Get full text
    Journal Article
  17. 17

    Synovial tissue response to treatment with Campath-1H by Ruderman, E M, Weinblatt, M E, Thurmond, L M, Pinkus, G S, Gravallese, E M

    Published in Arthritis and rheumatism (01-02-1995)
    “…Therapeutic trials in rheumatoid arthritis with the monoclonal antibody Campath-1H have demonstrated recurrent clinical synovitis in some patients, despite…”
    Get more information
    Journal Article
  18. 18

    Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon by Thurmond, L M, Brand, C M, Leventhal, B G, Finter, N B, Johnston, J M

    “…Serum specimens from 53 evaluable patients enrolled in a clinical trial of lymphoblastoid interferon in recurrent respiratory papillomatosis were screened for…”
    Get more information
    Journal Article
  19. 19

    Immunochemical characterization of human antibodies to lymphoblastoid interferon by Thurmond, L M, Reese, M J

    Published in Clinical and experimental immunology (01-12-1991)
    “…Antibodies produced in recurrent respiratory papillomatosis (RRP) patients treated with lymphoblastoid interferon (lyIFN) may neutralize antiviral activity or…”
    Get full text
    Journal Article
  20. 20

    Genetic variations in HLA-B region and hypersensitivity reactions to abacavir by Hetherington, Seth, Hughes, Arlene R, Mosteller, Michael, Shortino, Denise, Baker, Katherine L, Spreen, William, Lai, Eric, Davies, Kirstie, Handley, Abigail, Dow, David J, Fling, Mary E, Stocum, Michael, Bowman, Clive, Thurmond, Linda M, Roses, Allen D

    Published in The Lancet (British edition) (30-03-2002)
    “…Hypersensitivity to abacavir affects about 4% of patients who receive the drug for HIV-1 infection. We did a retrospective, case-control study to identify…”
    Get full text
    Journal Article